Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial

James D Chalmers; Remco S Djamin; Marjolijn Schouten; Holly R Keir; Brendan Tan; Joachim G J V Aerts; Jeffrey T-J Huang; Menno van der Eerden

doi:10.1183/23120541.00136-2018

Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial

James D Chalmers (Lead / Corresponding author), Remco S Djamin, Marjolijn Schouten, Holly R Keir, Brendan Tan, Joachim G J V Aerts, Jeffrey T-J Huang, Menno van der Eerden

Biomarker and Drug Analysis Laboratory

Research output: Contribution to journal › Article › peer-review

161 Downloads (Pure)

Abstract

Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1.

Original language	English
Pages (from-to)	1-4
Number of pages	4
Journal	ERJ Open Research
Volume	4
Issue number	4
DOIs	https://doi.org/10.1183/23120541.00136-2018
Publication status	Published - Oct 2018

Access to Document

10.1183/23120541.00136-2018Licence: CC BY-NC

Final Published VersionFinal published version, 326 KBLicence: CC BY-NC

Huang, Jeffrey
- Cardiovascular Research - Principal Investigator/Senior Lecturer (Tenure Track)
- Biomarker and Drug Analysis Laboratory
Person: Academic Related, Academic

Cite this

@article{a46639a039714e21b3f6ecaf5d5b64cd,

title = "Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial",

abstract = "Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1.",

author = "Chalmers, {James D} and Djamin, {Remco S} and Marjolijn Schouten and Keir, {Holly R} and Brendan Tan and Aerts, {Joachim G J V} and Huang, {Jeffrey T-J} and {van der Eerden}, Menno",

note = "British Lung Foundation GSK/BLF Chair of Respiratory Research",

year = "2018",

month = oct,

doi = "10.1183/23120541.00136-2018",

language = "English",

volume = "4",

pages = "1--4",

journal = "ERJ Open Research",

issn = "2312-0541",

publisher = "European Respiratory Society",

number = "4",

}

TY - JOUR

T1 - Circulating desmosine as a biomarker of azithromycin treatment response

T2 - a post hoc analysis of the COLUMBUS randomised controlled trial

AU - Chalmers, James D

AU - Djamin, Remco S

AU - Schouten, Marjolijn

AU - Keir, Holly R

AU - Tan, Brendan

AU - Aerts, Joachim G J V

AU - Huang, Jeffrey T-J

AU - van der Eerden, Menno

N1 - British Lung Foundation GSK/BLF Chair of Respiratory Research

PY - 2018/10

Y1 - 2018/10

N2 - Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1.

AB - Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1.

U2 - 10.1183/23120541.00136-2018

DO - 10.1183/23120541.00136-2018

M3 - Article

C2 - 30443554

SN - 2312-0541

VL - 4

SP - 1

EP - 4

JO - ERJ Open Research

JF - ERJ Open Research

IS - 4

ER -

Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial

Abstract

Access to Document

Fingerprint

Profiles

Huang, Jeffrey

Cite this